← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2005Last known activity
Dec 31, 2025
Timeline
2000s
- Jun 1, 2003
Sarcoma Alliance for Research through Collaboration— Founded
Drugs by trial phase (34 distinct, 28 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (25 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Bone Neoplasms
- Carney Complex
- Chondrosarcoma
- Chordoma
- Dermatofibrosarcoma
- Gastrointestinal Stromal Tumors
- Giant Cell Tumor of Bone
- Giant Cell Tumors
- Hemangiopericytoma
- Leiomyosarcoma
- Liposarcoma
- Neoplasms
- Nerve Sheath Neoplasms
- Neuroectodermal Tumors, Primitive, Peripheral
- Neurofibroma
- Neurofibromatoses
- Neurofibromatosis 1
- Neurofibrosarcoma
- Osteosarcoma
- Paraganglioma
- Rhabdomyosarcoma
- Sarcoma
- Sarcoma, Alveolar Soft Part
- Sarcoma, Ewing
- Uterine Neoplasms
Recent trials (29)
- NCT07104331Lead sponsorPhase 2Dec 31, 2025
- NCT06942442Lead sponsorPhase 2Oct 22, 2025
- NCT06208748Lead sponsorPhase 2Jul 31, 2024
- NCT04967521Lead sponsorPhase 3Nov 11, 2021
- NCT04803877Lead sponsorPhase 2Jun 4, 2021
- NCT04067115Lead sponsorPhase 1Oct 31, 2019
- NCT03433183Lead sponsorPhase 2Oct 31, 2018
- NCT03092323Lead sponsorPhase 2Jul 1, 2017
- NCT02342600Lead sponsorPhase 2Jan 1, 2017
- NCT02712567Lead sponsorN/AMar 9, 2016
- NCT02303262Lead sponsorPhase 2Sep 1, 2015
- NCT02301039Lead sponsorPhase 2Mar 1, 2015
- NCT02048371Lead sponsorPhase 2Jul 1, 2014
- NCT02044120Lead sponsorPhase 1May 1, 2014
- NCT02008877Lead sponsorPhase 1/Phase 2Dec 1, 2013
Details
- Founded
- Ann Arbor, MI, US Jun 1, 2003
- Last known activity
- Dec 31, 2025